Celcuity Presents Overall Survival Data from Phase 1b Study Evaluating Gedatolisib in Combination with Palbociclib and Endocrine Therapy at the 2024 San Antonio Breast Cancer Symposium
Stocks in this Quantisnow insightHealth Care
Quantisnow market dataNASDAQ
CELC
Celcuity Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Medical Specialities
- Listed since
- 2017
Get push alerts for CELC
Full CELC profile on Quantisnow Follow CELC and get a push notification the moment its next story breaks.